Neuroeffector transmission to arteries and veins in health and disease

$351,539P01FY2018HLNIH

Michigan State University, East Lansing MI

Investigators

Linked publications & trials

Paper 35943101 Paper 35410518 Paper 34223173 Paper 33929898 Paper 33815135 Paper 33776071 Paper 33734818 Paper 33540122 Paper 33197599 Paper 33006918 Paper 32767848 Paper 32402640 Paper 32019956 Paper 31774690 Paper 31731103 Paper 30721555 Paper 30567483 Paper 30354819 Paper 30189295 Paper 30118343 Paper 30051281 Paper 29957015 Paper 29758591 Paper 29454047 Paper 28985443 Paper 28974571 Paper 28842441 Paper 28715395 Paper 28667050 Paper 28655736 Paper 28333380 Paper 28228728 Paper 28212804 Paper 27926779 Paper 27813085 Paper 27738018 Paper 27652592 Paper 27588564 Paper 27530600 Paper 27324312 Paper 27288421 Paper 27225954 Paper 27199758 Paper 26968546 Paper 26862713 Paper 26637558 Paper 26611594 Paper 26432838 Paper 26381722 Paper 26320034 Paper 26049174 Paper 25910805 Paper 25817054 Paper 25599570 Paper 24904751 Paper 24726828 Paper 24629351 Paper 24075956 Paper 23937098 Paper 23559624 Paper 23397055 Paper 23177664 Paper 22974823 Paper 22331418 Paper 22307675 Paper 21997262 Paper 21937581 Paper 21890693 Paper 21885988 Paper 21841011 Paper 21357503 Paper 21357502 Paper 21357285 Paper 21196394 Paper 21131476 Paper 20881613 Paper 20662769 Paper 20599923 Paper 20398741 Paper 20335377 Paper 20215410 Paper 20053590 Paper 19907001 Paper 19719749 Paper 19716351 Paper 19571575 Paper 19297422 Paper 19114645 Paper 18660442 Paper 18606906 Paper 18565836 Paper 18485831 Paper 18295111 Paper 18087609 Paper 18081202 Paper 17973864 Paper 17904426 Paper 17761778 Paper 17698723 Paper 17383009

Abstract

Project Summary/Abstract - Project 2 The splanchnic circulation is supplied by sympathetic nerves which control resistance and capacitance. Elevated sympathetic nerve activity (SNA) increases resistance and decreases capacitance causing increased blood pressure. Dysregulation of SNA and dilator mechanisms contribute to obesity-related hypertension. We will study how obesity disrupts molecular control of norepinephrine (NE) and ATP release at the arterial and venous sympathetic neuroeffector junction. A novel concept guiding these studies is that mesenteric perivascular fat (mPVAT) is a source of inflammatory mediators and norepinephrine (NE) that can alter sympathetic function. Specific aim 1: Prejunctional alpha2 adrenergic receptors (alpha2ARs) regulate NE and ATP release from sympathetic nerves and alpha2AR function is impaired in obesity-associated hypertension. The mechanisms responsible for impairment are linked to inflammation. We will test the hypothesis that alpha2AR function is impaired due to the action of mPVAT-derived inflammatory mediators. Specific aim 2: NE and ATP constrict and NE and endothelial derived nitric oxide (NO) relax vascular smooth muscle. Pannexin-1 is a smooth muscle ATP permeable channel and ATP contributes to arterial constriction caused by NE. This conclusion is based only on studies of exogenously applied NE; pannexin-1 contributions to neurogenic arterial or venous constriction have not been established. These studies will test the hypothesis that pannexin-1 contributes to neurogenic constriction in mesenteric arteries and veins and that pannexin-1 expression and function and NE and NO dilator mechanisms are impaired in obesity-associated hypertension. Specific aim 3: This aim will focus on neurogenic constrictions and dilator mechanisms of human mesenteric arteries and veins obtained from obese patients undergoing gastric by-pass surgery and from non-obese patients undergoing intestinal or colonic resection. In addition to studies of basic mechanisms of sympathetic constriction of arteries and veins in the human splanchnic circulation, we will identify the mechanisms responsible for disruption of vascular tone and sympathetic neuroeffector transmission in obesity.

View original record on NIH RePORTER →